Cite

HARVARD Citation

    Komenda, M. et al. (2014). Assessment of the ability of the Privigen® purification process to deplete thrombogenic factor XIa from plasma. Vox sanguinis. 107 (1), pp. 26-36. [Online]. 
  
Back to record